Table 1.
Patient demographics, pre-operative variables and intra-operative outcomes
| TEA | ITM+fPCA | Pc | |
|---|---|---|---|
| n = 36 | n = 37 | ||
| Age (years)a | 58 (50–64) | 61 (58–69) | 0.118d |
| Gender ratio (M : F) | 11:25 | 17:20 | 0.176 |
| Body mass index (kg/m2)a | 25.5 (23.2–27.3) | 24.5 (22.7–26.8) | 0.275d |
| ASA score | 0.788 | ||
| 1 | 2 | 2 | |
| 2 | 27 | 30 | |
| 3 | 7 | 5 | |
| 4 | 0 | 0 | |
| Predicted Morbidity-POSSUM (%)a | 43.4 (31.8–64.0) | 58.9 (31.8–66.5) | 0.282d |
| Predicted Mortality-POSSUM (%)a | 2.2 (1.2–4.3) | 2.3 (1.2–4.4) | 0.326d |
| Aetiology of liver disease | 0.221 | ||
| Colorectal liver metastases | 27 | 34 | |
| HCC | 5 | 2 | |
| Cholangiocarcinoma | 2 | 0 | |
| Benign tumour | 2 | 1 | |
| Neo-adjuvant chemotherapy | 12 | 14 | 0.688 |
| Cirrhosis | 4 | 6 | 0.526 |
| Type of resection | 0.665 | ||
| Minor | 26 | 25 | |
| Major | 10 | 12 | |
| Pringle manoeuvre | 13 | 19 | 0.180 |
| Pringle time (min)a | 12.0 (10.0–15.0) | 12 (11.5–15.0) | 0.779 |
| Intra-operative blood loss (ml) | 0.017 | ||
| ≤500 | 29 | 20 | |
| 501–1000 | 4 | 16 | |
| 1001–2000 | 2 | 1 | |
| >2000 | 1 | 0 | |
| Intra-operative transfusion of PRBC (SU)a,b | 0 (0-0)/0.7 (2.1) | 0 (0–2)/0.8 (1.0) | 0.066d |
| Intra-operative time (min)a | 266 (200–362) | 323 (254–401) | 0.062d |
a
Values are median (IQR).
b
Values are mean (SD) otherwise absolute numbers.
c
χ2 test, except
d
the Mann–Whitney U-test.
PRBC, packed red cells; SU, standard unit; HCC, hepatocellular carcinoma.